1.
Kovač, MD, PhD V, Franko A, Dodič-Fikfak M, Arnerić N, Dolžan V. Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma. Radiol Oncol [Internet]. 2015 Oct. 8 [cited 2026 Sep. 4];49(3). Available from: https://www.radioloncol.com/index.php/ro/article/view/2368